Article
The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
PloS one - 1 Jan 2013
Pastor-Idoate Salvador, Rodríguez-Hernández Irene, Rojas Jimena, Fernández Itziar, García-Gutiérrez María T, Ruiz-Moreno José M, Rocha-Sousa Amandio, Ramkissoon Yashin, Harsum Steven, MacLaren Robert E, Charteris David, VanMeurs Jan C, González-Sarmiento Rogelio, Pastor José C
Abstract excerpt
Proliferative vitreoretinopathy (PVR) is still the major cause of failure in retinal detachment (RD) surgery. It is believed that down-regulation in the p53 pathway could be an important key in PVR pathogenesis. The purpose was to evaluate the impact of T309G MDM2 polymorphism (rs2279744) in PVR. Distribution of T309G MDM2 genotypes among European subjects undergoing RD surgery was evaluated. Proportions of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
